Acesso livre
Acesso livre

Cardiologia

Recomendações clínicas para diagnóstico e monitoramento de pacientes com cardiomiopatia amiloide transtiretina.

11 Jul, 2022 | 13:53h

Clinical recommendations to diagnose and monitor patients with transthyretin amyloid cardiomyopathy in Asia – Clinical Cardiology

Conteúdos relacionados:

Characteristics and natural history of early-stage cardiac transthyretin amyloidosis – European Heart Journal

Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis – 2021 – Arquivos Brasileiros de Cardiologia

AHA Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis.

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases – European Heart Journal

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association – Circulation

Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis – Canadian Journal of Cardiology

AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management – JACC: CardioOncology

Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis – Circulation: Heart Failure

 


Diretrizes de consenso sobre diagnóstico e tratamento de apneia obstrutiva do sono em pacientes com doença cardiovascular.

11 Jul, 2022 | 13:51h

Asian Pacific Society of Cardiology Consensus Statements on the Diagnosis and Management of Obstructive Sleep Apnoea in Patients with Cardiovascular Disease – European Cardiovascular Review

 


Estudo transversal | Comparação da exposição à radiação entre ecocardiografistas intervencionistas, cardiologistas intervencionistas e ultrassonografistas durante intervenções cardíacas estruturais percutâneas.

11 Jul, 2022 | 13:46h

Comparison of Radiation Exposure Among Interventional Echocardiographers, Interventional Cardiologists, and Sonographers During Percutaneous Structural Heart Interventions – JAMA Network Open

 


Revisão sistemática e metanálise dose-resposta de estudos de coorte prospectiva | Ingestão de ovos e colesterol na dieta e risco de mortalidade por todas as causas, cardiovascular e por câncer.

11 Jul, 2022 | 13:33h

Egg and Dietary Cholesterol Intake and Risk of All-Cause, Cardiovascular, and Cancer Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies – Frontiers in Nutrition

 


Análise post-hoc | Os inibidores de SGLT2 são capazes de reduzir o risco de nefrolitíase?

8 Jul, 2022 | 11:14h

Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition? – The Journal of Clinical Endocrinology & Metabolism

 


Análise post-hoc | Os inibidores de SGLT2 são capazes de reduzir o risco de hiperuricemia e gota?

8 Jul, 2022 | 11:12h

Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial – European Heart Journal

 


Regurgitação tricúspide: avanços recentes no entendimento da fisiopatologia, dos níveis de gravidade e dos desfechos.

8 Jul, 2022 | 11:10h

Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome – European Heart Journal – Cardiovascular Imaging

 


Estudo de coorte baseado em registro | Associação entre gota e desfechos cardiovasculares em adultos sem histórico de doença cardiovascular.

8 Jul, 2022 | 11:06h

Association between gout and cardiovascular outcomes in adults with no history of cardiovascular disease: large data linkage study in New Zealand – BMJ Medicine

 

Comentário no Twitter

 


Estudo de coorte baseado em registro | Intervenções em adultos com reparo prévio em coarctação da aorta.

8 Jul, 2022 | 11:05h

Interventions in Adults With Repaired Coarctation of the Aorta – Journal of the American Heart Association

 


M-A | Fatores de risco da cardiotoxicidade induzida por antraciclina no tratamento do câncer de mama.

8 Jul, 2022 | 10:57h

Risk Factors for Anthracycline-Induced Cardiotoxicity in Breast Cancer Treatment: A Meta-Analysis – Frontiers in Oncology

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.